A6541412
Olprinone , 98% , 106730-54-5
| Pack Size | Price | Stock | Quantity |
| 25MG | RMB479.20 | In Stock |
|
| 100MG | RMB1318.40 | In Stock |
|
| 500MG | RMB3999.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | >300° |
| Density | 1.34±0.1 g/cm3(Predicted) |
| storage temp. | Sealed in dry,Store in freezer, under -20°C |
| solubility | DMSO |
| form | Powder |
| pka | 6.59±0.10(Predicted) |
| color | White to off-white |
| InChI | InChI=1S/C14H10N4O/c1-9-12(6-11(7-15)14(19)17-9)10-2-3-13-16-4-5-18(13)8-10/h2-6,8H,1H3,(H,17,19) |
| InChIKey | JPAWFIIYTJQOKW-UHFFFAOYSA-N |
| SMILES | C1(=O)NC(C)=C(C2=CN3C=CN=C3C=C2)C=C1C#N |
| CAS DataBase Reference | 106730-54-5(CAS DataBase Reference) |
Description and Uses
Oprinone is an injection developed by Japan Co., Ltd. for the treatment of acute heart failure. It is a specific PDEⅢ inhibitor that selectively blocks cAMP and has high selectivity for the inhibition of human cardiac PDEⅢ.
Olprinone is used in the treatment of acute myocardial insufficiency.
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P305+P351+P338 |
